China-based Koutech Robotics (Shanghai) Co., Ltd, a leading ultra-micro, high-precision surgical robot platform company, has reportedly raised “hundreds of millions” of renminbi in a Series A financing round. The round was led by Qiming Venture Partners, with contributions from Proxima Ventures, DNE Capital, Lingang Blue Bay Fund, Winfast Holding, and existing investor TF Capital. The proceeds will be directed towards product research and development, team expansion, and the construction of GMP-compliant facilities.
Platform and Innovation
Koutech Robotics is recognized for developing the world’s first robotic platform focused on small and delicate surgery. The platform enables the creation of general-purpose microsurgical robots, ophthalmic surgical robots, and trans-gastrointestinal endoscopy robots. This innovation aims to enhance precision and efficiency in surgical procedures, addressing significant unmet needs in the medical field.
Future Outlook
The Series A funding marks a significant milestone for Koutech Robotics as it seeks to expand its capabilities and market presence. With the support of leading investors, the company is well-positioned to drive innovation in surgical robotics, ultimately contributing to improved patient outcomes and healthcare delivery.-Fineline Info & Tech
